Silo Pharma Faces Delisting Concerns
Ticker: SILO · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-actions
TL;DR
Silo Pharma might get delisted, stock could be toast.
AI Summary
Silo Pharma, Inc. filed an 8-K on July 3, 2025, reporting a notice of delisting or failure to satisfy continued listing rules as of June 27, 2025. The company, formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc., is incorporated in Nevada and has its principal executive offices in Sarasota, Florida.
Why It Matters
This filing indicates potential issues with Silo Pharma's continued listing on an exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Numbers
- 001-41512 — Commission File Number (Identifies the company's filing history with the SEC.)
- 20250627 — Date of earliest event reported (Marks the date when the delisting concern arose.)
- 20250703 — Filing Date (Indicates when the company officially reported this event to the SEC.)
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- Uppercut Brands, Inc. (company) — Former company name
- Point Capital, Inc. (company) — Former company name
- Gold Swap Inc (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Sarasota, FL (location) — Principal executive offices
FAQ
What specific listing rule or standard has Silo Pharma, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Silo Pharma, Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the exact date of the delisting notice?
The earliest event reported, which is the date of the delisting notice, is June 27, 2025.
What was Silo Pharma, Inc. previously named?
Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc.
In which state is Silo Pharma, Inc. incorporated?
Silo Pharma, Inc. is incorporated in Nevada.
Where are Silo Pharma, Inc.'s principal executive offices located?
Silo Pharma, Inc.'s principal executive offices are located at 677 N. Washington Boulevard, Sarasota, FL 34236.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding Silo Pharma, Inc. (SILO).